Insider Transactions in Q3 2023 at Rayze Bio, Inc. (RYZB)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 19
2023
|
Redmile Group, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,857,706
+32.61%
|
-
|
|
Sep 19
2023
|
Maha Katabi |
BUY
Open market or private purchase
|
Indirect |
472,222
+16.33%
|
$8,499,996
$18.0 P/Share
|
|
Sep 19
2023
|
Maha Katabi |
BUY
Conversion of derivative security
|
Indirect |
1,947,306
+50.0%
|
-
|
|
Sep 19
2023
|
Viking Global Investors LP |
BUY
Open market or private purchase
|
Indirect |
2,777,778
+18.39%
|
$50,000,004
$18.0 P/Share
|
|
Sep 19
2023
|
Viking Global Investors LP |
BUY
Conversion of derivative security
|
Indirect |
10,507,622
+41.59%
|
-
|
|
Sep 19
2023
|
Ven Bio Global Strategic Fund Iii, L.P. |
BUY
Conversion of derivative security
|
Direct |
5,158,162
+24.4%
|
-
|
|
Sep 19
2023
|
Wellington Biomedical Innovation Master Investors (Cayman) Ii L.P. |
BUY
Conversion of derivative security
|
Direct |
1,557,846
+50.0%
|
-
|